|Articles|September 1, 2017
- Pharmaceutical Executive-09-01-2017
- Volume 37
- Issue 9
Pharmaceutical Executive, September 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Pharm Exec's 16th Annual Industry Auditalmost 9 years ago
The Supply Chain: What Price Patient Centricity?almost 9 years ago
Drug Serialization for DSCSA Compliance Benefits Everyonealmost 9 years ago
Pharm Exec's 16th Annual Industry Audit (Overview)about 9 years ago
You Are Pharmaabout 9 years ago
Leading With Patients in Mind: Cynthia Schwalmabout 9 years ago
FDA, Industry Prepare for New User Fee Initiativesabout 9 years ago
Data Inflection Pointabout 9 years ago
UK Unveils Post-Brexit Life Sciences Strategyabout 9 years ago
Seizing the Opportunity in STEMAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
The Agentic AI Revolution in Biopharma
3
340B Under Pressure: Inside Pharma's Push for Greater Clarity
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5